Renal protective effects of helix B surface polypeptide in rats with puromycin aminonucleoside nephropathy.
helix B 表面多肽在患有 puromycin aminonucleoside 腎病的老鼠中的腎臟保護作用。
Ren Fail 2024-08-27
Bushen Huoxue formula protects against renal fibrosis and pyroptosis in chronic kidney disease by inhibiting ROS/NLRP3-mediated inflammasome activation.
補腎活血方抑制 ROS/NLRP3 介導的發炎小體活化,保護慢性腎病患者免受腎纖維化和焦亡的影響。
Ren Fail 2024-05-24
Supplemented Gegen Qinlian Decoction Formula attenuates podocyte mitochondrial fission and renal fibrosis in diabetic kidney disease by inhibiting TNF-α-mediated necroptosis, compared with empagliflozin.
補充的對秦連湯方劑通過抑制TNF-α介導的壞死性凋亡,減輕糖尿病腎病中的足細胞線粒體分裂和腎纖維化,與empagliflozin相比。
J Ethnopharmacol 2024-07-18
The immunosuppressive drug LF15-0195 acts also on glomerular lesions, by a change in cytoskeleton distribution in podocyte.
免疫抑制藥物 LF15-0195 也對腎小球病變產生作用,通過改變足細胞中的細胞骨架分佈。
Am J Nephrol 2024-07-29
Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients.
血漿置換、免疫抑制療法與抗-GBM 疾病預後:107 名患者的隊列研究。
Ren Fail 2024-09-11
Identification of natriuretic peptide receptor A (NPR-A)-related gene expression signatures in podocytes <i>in vivo</i> reveals baseline control of protective pathways.
在小鼠體內識別與利尿肽受體 A (NPR-A) 相關的足細胞基因表達特徵顯示保護途徑的基線控制。
Am J Physiol Renal Physiol 2024-09-19